Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Nanette Santoro to Menopause

This is a "connection" page, showing publications Nanette Santoro has written about Menopause.

 
Connection Strength
  
 
 
21.950
  
  1. Hofmann G, Santoro N. Navigating the Debate on Menopausal Hormonal Therapy and Practical Prescribing. Obstet Gynecol Clin North Am. 2026 Sep; 53(3):411-422.
    View in: PubMed
    Score: 0.763
  2. Santoro N. Novel nonhormonal treatments for vasomotor symptoms of menopause. Curr Opin Obstet Gynecol. 2025 Aug 01; 37(4):193-197.
    View in: PubMed
    Score: 0.710
  3. Santoro N, Neal-Perry G, Stute P, Blogg M, Mancuso S, Morga A, Ottery FD, Siddiqui E. Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy. Curr Med Res Opin. 2025 Feb; 41(2):375-384.
    View in: PubMed
    Score: 0.703
  4. Santoro N. Understanding the menopause journey. Climacteric. 2025 08; 28(4):384-388.
    View in: PubMed
    Score: 0.699
  5. Green R, Metcalf CA, Santoro N. Mental Well-being in Menopause. Obstet Gynecol Clin North Am. 2025 Mar; 52(1):51-66.
    View in: PubMed
    Score: 0.688
  6. Santoro N. Basics of the menopause transition. Menopause. 2024 Oct 01; 31(10):921-922.
    View in: PubMed
    Score: 0.682
  7. Santoro N. Neurokinin receptor antagonists as potential nonhormone treatments for vasomotor symptoms. Menopause. 2024 Oct 01; 31(10):923-925.
    View in: PubMed
    Score: 0.678
  8. Johnson KA, Martin N, Nappi RE, Neal-Perry G, Shapiro M, Stute P, Thurston RC, Wolfman W, English M, Franklin C, Lee M, Santoro N. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. J Clin Endocrinol Metab. 2023 07 14; 108(8):1981-1997.
    View in: PubMed
    Score: 0.627
  9. Santoro N. What's up (or down) with lipids in menopause? Fertil Steril. 2023 06; 119(6):1068.
    View in: PubMed
    Score: 0.613
  10. Santoro N, Flyckt R, Davis A, Finkelstein J, Crawford S, Sun F, Derby C, Morrison A, Sluss P, Zhang H. Anti-Müllerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause. Obstet Gynecol. 2023 02 01; 141(2):331-340.
    View in: PubMed
    Score: 0.605
  11. Santoro N, Liss J. Compounded Bioidentical Hormones: Myths and Realities. Clin Obstet Gynecol. 2021 12 01; 64(4):793-802.
    View in: PubMed
    Score: 0.561
  12. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021 01 01; 106(1):1-15.
    View in: PubMed
    Score: 0.526
  13. Finkelstein JS, Lee H, Karlamangla A, Neer RM, Sluss PM, Burnett-Bowie SM, Darakananda K, Donahoe PK, Harlow SD, Prizand SH, Joffe H, Kumar A, Martin DE, McConnell D, Merrilat S, Morrison A, Pastore LM, Randolph JF, Greendale GA, Santoro N. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
    View in: PubMed
    Score: 0.500
  14. Santoro N, El Khoudary SR, Nasr A, Gold EB, Greendale G, McConnell D, Neal-Perry G, Pavlovic J, Derby C, Crawford S. Daily luteal serum and urinary hormone profiles in the menopause transition: Study of Women's Health Across the Nation. Menopause. 2020 02; 27(2):127-133.
    View in: PubMed
    Score: 0.494
  15. Allshouse A, Pavlovic J, Santoro N. Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms. Obstet Gynecol Clin North Am. 2018 Dec; 45(4):613-628.
    View in: PubMed
    Score: 0.452
  16. Santoro N, Kravitz HM. The Disruptive Changes of Midlife: A Biopsychosocial Adventure. Obstet Gynecol Clin North Am. 2018 12; 45(4):xv-xvii.
    View in: PubMed
    Score: 0.452
  17. Thurston RC, Bhasin S, Chang Y, Barinas-Mitchell E, Matthews KA, Jasuja R, Santoro N. Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women. J Clin Endocrinol Metab. 2018 08 01; 103(8):3070-3077.
    View in: PubMed
    Score: 0.445
  18. Santoro N. Feed a hot flash, starve a hot flash? Menopause. 2017 01; 24(1):1-2.
    View in: PubMed
    Score: 0.399
  19. Umland EM, Karel L, Santoro N. Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause. Pharmacotherapy. 2016 05; 36(5):548-61.
    View in: PubMed
    Score: 0.381
  20. Grindler NM, Santoro NF. Menopause and exercise. Menopause. 2015 Dec; 22(12):1351-8.
    View in: PubMed
    Score: 0.370
  21. Pinkerton JV, Santoro N. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause. 2015 Sep; 22(9):926-36.
    View in: PubMed
    Score: 0.364
  22. Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am. 2015 Sep; 44(3):497-515.
    View in: PubMed
    Score: 0.364
  23. Santoro N, Pal L. Menopause and Perimenopause. Preface. Endocrinol Metab Clin North Am. 2015 Sep; 44(3):xvii-xviii.
    View in: PubMed
    Score: 0.364
  24. Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal symptoms. Fertil Steril. 2014 Apr; 101(4):905-15.
    View in: PubMed
    Score: 0.328
  25. Santoro N, Sutton-Tyrrell K. The SWAN song: Study of Women's Health Across the Nation's recurring themes. Obstet Gynecol Clin North Am. 2011 Sep; 38(3):417-23.
    View in: PubMed
    Score: 0.276
  26. Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids. 2011 Jun; 76(7):627-35.
    View in: PubMed
    Score: 0.267
  27. Green R, Polotsky AJ, Wildman RP, McGinn AP, Lin J, Derby C, Johnston J, Ram KT, Crandall CJ, Thurston R, Gold E, Weiss G, Santoro N. Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Climacteric. 2010 Aug; 13(4):376-84.
    View in: PubMed
    Score: 0.256
  28. Santoro N, Fan M, Maslow B, Schoenbaum E. Women and HIV infection: the makings of a midlife crisis. Maturitas. 2009 Nov 20; 64(3):160-4.
    View in: PubMed
    Score: 0.241
  29. Green R, Santoro N. Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond). 2009 Mar; 5(2):127-33.
    View in: PubMed
    Score: 0.232
  30. Santoro N. Symptoms of menopause: hot flushes. Clin Obstet Gynecol. 2008 Sep; 51(3):539-48.
    View in: PubMed
    Score: 0.224
  31. Santoro N, Crawford SL, Lasley WL, Luborsky JL, Matthews KA, McConnell D, Randolph JF, Gold EB, Greendale GA, Korenman SG, Powell L, Sowers MF, Weiss G. Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab. 2008 May; 93(5):1711-21.
    View in: PubMed
    Score: 0.216
  32. Santoro N, Lo Y, Moskaleva G, Arnsten JH, Floris-Moore M, Howard AA, Adel G, Zeitlian G, Schoenbaum EE. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause. 2007 Sep-Oct; 14(5):859-65.
    View in: PubMed
    Score: 0.209
  33. Santoro N, Brockwell S, Johnston J, Crawford SL, Gold EB, Harlow SD, Matthews KA, Sutton-Tyrrell K. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause. 2007 May-Jun; 14(3 Pt 1):415-24.
    View in: PubMed
    Score: 0.204
  34. Niklaus AL, Aubuchon M, Zapantis G, Li P, Qian H, Isaac B, Kim MY, Adel G, Pollard JW, Santoro NF. Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women. Hum Reprod. 2007 Jun; 22(6):1778-88.
    View in: PubMed
    Score: 0.202
  35. Kantarci K, Kara F, Tosakulwong N, Fought AJ, Schwarz CG, Senjem ML, Kendall-Thomas J, Min P, Lowe VJ, Jack CR, Kapoor E, Fields JA, Bailey KR, James TT, Faubion L, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE. Long-term amyloid PET and MRI outcomes in a menopausal hormone therapy trial. Alzheimers Dement. 2026 02; 22(2):e71067.
    View in: PubMed
    Score: 0.187
  36. Santoro N. The menopausal transition. Am J Med. 2005 Dec 19; 118 Suppl 12B:8-13.
    View in: PubMed
    Score: 0.186
  37. Schoenbaum EE, Hartel D, Lo Y, Howard AA, Floris-Moore M, Arnsten JH, Santoro N. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005 Nov 15; 41(10):1517-24.
    View in: PubMed
    Score: 0.183
  38. Santoro NF, Lawley SD, Sammel MD, Johnson J. Prolonging youth or prolonging perimenopause? Beware the Monkey's Paw. Menopause. 2025 Oct 01; 32(10):978-982.
    View in: PubMed
    Score: 0.183
  39. Winkles JF, Colvin A, El Khoudary SR, Santoro N, Sammel M, Crawford S. Using a Composite Summary of Daily Sex Hormones to Gauge Time Until Menopause: A Focus on Pregnanediol Glucuronide (PDG). J Clin Endocrinol Metab. 2025 Sep 16; 110(10):2832-2844.
    View in: PubMed
    Score: 0.182
  40. Faubion LL, Mak E, Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Reid RI, Schwarz CG, Kendall-Thomas J, Kapoor E, Fields JA, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Brinton EA, Malek-Ahmadi M, Cedars M, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Long-term effects of 4 years of menopausal hormone therapy on white matter integrity. Menopause. 2025 Sep 01; 32(9):818-828.
    View in: PubMed
    Score: 0.182
  41. Zalles L, Santoro N. Nonhormonal treatments for vasomotor symptoms. Curr Opin Obstet Gynecol. 2025 Oct 01; 37(5):326-331.
    View in: PubMed
    Score: 0.180
  42. Lawley SD, Santoro N, Johnson J. On Modeling Ovarian Aging and Menopause Timing. Bull Math Biol. 2025 Jun 28; 87(8):104.
    View in: PubMed
    Score: 0.180
  43. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005 Mar; 8(1):3-12.
    View in: PubMed
    Score: 0.176
  44. Santoro N, Chervenak JL. The menopause transition. Endocrinol Metab Clin North Am. 2004 Dec; 33(4):627-36.
    View in: PubMed
    Score: 0.173
  45. Santoro N, Lasley B, McConnell D, Allsworth J, Crawford S, Gold EB, Finkelstein JS, Greendale GA, Kelsey J, Korenman S, Luborsky JL, Matthews K, Midgley R, Powell L, Sabatine J, Schocken M, Sowers MF, Weiss G. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004 Jun; 89(6):2622-31.
    View in: PubMed
    Score: 0.167
  46. Shapiro C M M, Cano A, Nappi RE, Santoro N, English ML, Mancuso S, Morga A, Siddiqui E, Valluri U, Ottery FD. Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause. Maturitas. 2024 Aug; 186:107999.
    View in: PubMed
    Score: 0.166
  47. Santoro N, Nappi RE, Neal-Perry G, English M, King DD, Yamaguchi Y, Ottery FD. Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2). Menopause. 2024 Apr 01; 31(4):247-257.
    View in: PubMed
    Score: 0.165
  48. Cano A, Nappi RE, Santoro N, Stute P, Blogg M, English ML, Morga A, Scrine L, Siddiqui E, Ottery FD. Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials. BJOG. 2024 Aug; 131(9):1296-1305.
    View in: PubMed
    Score: 0.163
  49. Berga SL, Merkison J, Schirmer DA, Kawwass JF, Santoro N. Should menopause care be part of the skill set of a reproductive endocrinology and infertility specialist? Fertil Steril. 2024 02; 121(2):213-218.
    View in: PubMed
    Score: 0.161
  50. Liss J, Pettigrew J, Santoro N. Type and age of menopause: potential implications for female sexual health. J Sex Med. 2023 06 28; 20(7):921-924.
    View in: PubMed
    Score: 0.156
  51. Zapantis G, Santoro N. The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab. 2003 Mar; 17(1):33-52.
    View in: PubMed
    Score: 0.153
  52. Hickey M, Hunter MS, Santoro N, Ussher J. Normalising menopause. BMJ. 2022 06 15; 377:e069369.
    View in: PubMed
    Score: 0.145
  53. Santoro N. The menopause transition: an update. Hum Reprod Update. 2002 Mar-Apr; 8(2):155-60.
    View in: PubMed
    Score: 0.143
  54. Peters BA, Xue X, Sheira LA, Qi Q, Sharma A, Santoro N, Alcaide ML, Ofotokun I, Adimora AA, McKay HS, Tien PC, Michel KG, Gustafson D, Turan B, Landay AL, Kaplan RC, Weiser SD. Menopause Is Associated With Immune Activation in Women With HIV. J Infect Dis. 2022 01 18; 225(2):295-305.
    View in: PubMed
    Score: 0.141
  55. Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N, Kohrt WM. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring). 2022 01; 30(1):14-27.
    View in: PubMed
    Score: 0.141
  56. Kracht CL, Romain JS, Hardee JC, Santoro N, Redman LM, Marlatt KL. "It just seems like people are talking about menopause, but nobody has a solution": A qualitative exploration of menopause experiences and preferences for weight management among Black women. Maturitas. 2022 03; 157:16-26.
    View in: PubMed
    Score: 0.140
  57. El Khoudary SR, Qi M, Chen X, Matthews K, Allshouse AA, Crawford SL, Derby CA, Thurston RC, Kazlauskaite R, Barinas-Mitchell E, Santoro N. Patterns of menstrual cycle length over the menopause transition are associated with subclinical atherosclerosis after menopause. Menopause. 2021 10 11; 29(1):8-15.
    View in: PubMed
    Score: 0.139
  58. Lersten I, Clain E, Santoro N. Use of Hormone Therapy in Women with Early Menopause and Premature Ovarian Insufficiency. Semin Reprod Med. 2020 09; 38(4-05):302-308.
    View in: PubMed
    Score: 0.132
  59. Santoro N, Waldbaum A, Lederman S, Kroll R, Fraser GL, Lademacher C, Skillern L, Young J, Ramael S. Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA). Menopause. 2020 12; 27(12):1350-1356.
    View in: PubMed
    Score: 0.131
  60. Pinkerton JV, Faubion SS, Kaunitz AM, Liu JH, Manson JE, Santoro NF, Shifren JL, Stuenkel CA. The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy. Menopause. 2020 11; 27(11):1199-1201.
    View in: PubMed
    Score: 0.130
  61. Stuenkel CA, Santoro NF, Laughlin-Tommaso SK, Black A, Joffe H, Su HI. NAMS 2019 Pre-Meeting Symposium, September 2019, Chicago Illinois: The Perimenopause. Menopause. 2020 07; 27(7):735-745.
    View in: PubMed
    Score: 0.127
  62. Fraser GL, Lederman S, Waldbaum A, Kroll R, Santoro N, Lee M, Skillern L, Ramael S. A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause. Menopause. 2020 04; 27(4):382-392.
    View in: PubMed
    Score: 0.125
  63. Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause. 2019 09; 26(9):1071-1084.
    View in: PubMed
    Score: 0.120
  64. Santoro N, Banwell T, Tortoriello D, Lieman H, Adel T, Skurnick J. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol. 1998 Apr; 178(4):732-41.
    View in: PubMed
    Score: 0.109
  65. Cintron D, Lahr BD, Bailey KR, Santoro N, Lloyd R, Manson JE, Neal-Perry G, Pal L, Taylor HS, Wharton W, Naftolin F, Harman SM, Miller VM. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause. 2018 02; 25(2):145-153.
    View in: PubMed
    Score: 0.107
  66. Paramsothy P, Harlow SD, Nan B, Greendale GA, Santoro N, Crawford SL, Gold EB, Tepper PG, Randolph JF. Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women's Health Across the Nation. Menopause. 2017 02; 24(2):142-149.
    View in: PubMed
    Score: 0.100
  67. Thurston RC, Chang Y, von Känel R, Barinas-Mitchell E, Jennings JR, Hall MH, Santoro N, Buysse DJ, Matthews KA. Sleep Characteristics and Carotid Atherosclerosis Among Midlife Women. Sleep. 2017 Feb 01; 40(2).
    View in: PubMed
    Score: 0.100
  68. El Khoudary SR, Santoro N, Chen HY, Tepper PG, Brooks MM, Thurston RC, Janssen I, Harlow SD, Barinas-Mitchell E, Selzer F, Derby CA, Jackson EA, McConnell D, Matthews KA. Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause. Eur J Prev Cardiol. 2016 May; 23(7):694-703.
    View in: PubMed
    Score: 0.091
  69. Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nat Rev Dis Primers. 2015 04 23; 1:15004.
    View in: PubMed
    Score: 0.089
  70. Allshouse AA, Semple AL, Santoro NF. Evidence for prolonged and unique amenorrhea-related symptoms in women with premature ovarian failure/primary ovarian insufficiency. Menopause. 2015 Feb; 22(2):166-74.
    View in: PubMed
    Score: 0.087
  71. Polotsky AJ, Allshouse AA, Crawford SL, Harlow SD, Khalil N, Kazlauskaite R, Santoro N, Legro RS. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab. 2014 Jun; 99(6):2120-7.
    View in: PubMed
    Score: 0.082
  72. Wildman RP, Tepper PG, Crawford S, Finkelstein JS, Sutton-Tyrrell K, Thurston RC, Santoro N, Sternfeld B, Greendale GA. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2012 Sep; 97(9):E1695-704.
    View in: PubMed
    Score: 0.073
  73. Polotsky AJ, Allshouse A, Crawford SL, Harlow SD, Khalil N, Santoro N, Legro RS. Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab. 2012 Jun; 97(6):E868-77.
    View in: PubMed
    Score: 0.072
  74. Santoro N. Update in hyper- and hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 2011 Nov; 96(11):3281-8.
    View in: PubMed
    Score: 0.070
  75. Zhang K, Zeitlian G, Adel G, Santoro NF, Pal L. Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls. Menopause. 2011 Aug; 18(8):880-5.
    View in: PubMed
    Score: 0.068
  76. Lipton LR, Santoro N, Taylor H, Kidwai N, Isaac B, Magnani M, Pal L. Assessing comprehension of clinical research. Contemp Clin Trials. 2011 Sep; 32(5):608-13.
    View in: PubMed
    Score: 0.067
  77. Crawford S, Santoro N, Laughlin GA, Sowers MF, McConnell D, Sutton-Tyrrell K, Weiss G, Vuga M, Randolph J, Lasley B. Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab. 2009 Aug; 94(8):2945-51.
    View in: PubMed
    Score: 0.059
  78. Fan MD, Maslow BS, Santoro N, Schoenbaum E. HIV and the menopause. Menopause Int. 2008 Dec; 14(4):163-8.
    View in: PubMed
    Score: 0.057
  79. Hartel D, Lo Y, Bauer C, Budner N, Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Schoenbaum EE. Attitudes toward menopause in HIV-infected and at-risk women. Clin Interv Aging. 2008; 3(3):561-6.
    View in: PubMed
    Score: 0.053
  80. Johnston JM, Colvin A, Johnson BD, Santoro N, Harlow SD, Bairey Merz CN, Sutton-Tyrrell K. Comparison of SWAN and WISE menopausal status classification algorithms. J Womens Health (Larchmt). 2006 Dec; 15(10):1184-94.
    View in: PubMed
    Score: 0.050
  81. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab. 2006 Oct; 91(10):3697-710.
    View in: PubMed
    Score: 0.049
  82. Matthews KA, Santoro N, Lasley B, Chang Y, Crawford S, Pasternak RC, Sutton-Tyrrell K, Sowers M. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab. 2006 May; 91(5):1789-95.
    View in: PubMed
    Score: 0.047
  83. Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF, Schocken M, Skurnick J, Ory MG, Sutton-Tyrrell K. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues. 2005 Jul-Aug; 15(4):179-86.
    View in: PubMed
    Score: 0.045
  84. Mitro SD, Waetjen LE, Lee C, Wise LA, Zaritsky E, Harlow SD, El Khoudary SR, Santoro N, Solomon DH, Thurston RC, Hedderson MM. Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2025 May 19; 110(6):e1934-e1942.
    View in: PubMed
    Score: 0.045
  85. Miller SA, Santoro N, Lo Y, Howard AA, Arnsten JH, Floris-Moore M, Moskaleva G, Schoenbaum EE. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005 May-Jun; 12(3):348-56.
    View in: PubMed
    Score: 0.044
  86. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S, Lasley WL, Luborsky JL, McConnell D, Sowers MF, Weiss G. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab. 2005 Aug; 90(8):4836-45.
    View in: PubMed
    Score: 0.044
  87. Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 01; 32(1):12-22.
    View in: PubMed
    Score: 0.043
  88. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA. 2004 Dec 22; 292(24):2991-6.
    View in: PubMed
    Score: 0.043
  89. Torréns JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N, Weiss G. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care. 2004 Feb; 27(2):354-61.
    View in: PubMed
    Score: 0.041
  90. Santoro N, Isaac B, Neal-Perry G, Adel T, Weingart L, Nussbaum A, Thakur S, Jinnai H, Khosla N, Barad D. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab. 2003 Nov; 88(11):5502-9.
    View in: PubMed
    Score: 0.040
  91. Kracht CL, St Romain J, Hardee JC, Santoro N, Redman LM, Marlatt KL. "Weight loss is my goal and being healthy is my goal? I can get over the hot flashes": a qualitative exploration of menopausal transition experiences and preferences for weight management among White women. Menopause. 2023 10 01; 30(10):1022-1032.
    View in: PubMed
    Score: 0.040
  92. Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause-Biology, consequences, supportive care, and therapeutic options. Cell. 2023 09 14; 186(19):4038-4058.
    View in: PubMed
    Score: 0.040
  93. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab. 2003 Apr; 88(4):1516-22.
    View in: PubMed
    Score: 0.038
  94. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris). 2003 Apr; 64(2):87-92.
    View in: PubMed
    Score: 0.038
  95. Lederman S, Ottery FD, Cano A, Santoro N, Shapiro M, Stute P, Thurston RC, English M, Franklin C, Lee M, Neal-Perry G. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023 04 01; 401(10382):1091-1102.
    View in: PubMed
    Score: 0.038
  96. Neal-Perry G, Cano A, Lederman S, Nappi RE, Santoro N, Wolfman W, English M, Franklin C, Valluri U, Ottery FD. Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Obstet Gynecol. 2023 04 01; 141(4):737-747.
    View in: PubMed
    Score: 0.038
  97. Christmas M, Janssen I, Joffe H, Upchurch D, Santoro N, Kravitz HM. Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women's Health Across the Nation (SWAN). Menopause. 2022 12 01; 29(12):1357-1364.
    View in: PubMed
    Score: 0.037
  98. Lasley BL, Santoro N, Randolf JF, Gold EB, Crawford S, Weiss G, McConnell DS, Sowers MF. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab. 2002 Aug; 87(8):3760-7.
    View in: PubMed
    Score: 0.037
  99. Pal L, Morgan K, Santoro NF, Manson JE, Taylor HS, Miller VM, Brinton EA, Lobo R, Neal-Perry G, Cedars MI, Harman SM, James TT, Gleason CE. Cardiometabolic measures and cognition in early menopause - Analysis of baseline data from a randomized controlled trial. Maturitas. 2022 08; 162:58-65.
    View in: PubMed
    Score: 0.036
  100. Peters BA, Lin J, Qi Q, Usyk M, Isasi CR, Mossavar-Rahmani Y, Derby CA, Santoro N, Perreira KM, Daviglus ML, Kominiarek MA, Cai J, Knight R, Burk RD, Kaplan RC. Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos. mSystems. 2022 06 28; 7(3):e0027322.
    View in: PubMed
    Score: 0.036
  101. Peters BA, Xue X, Wang Z, Usyk M, Santoro N, Sharma A, Anastos K, Tien PC, Golub ET, Weber KM, Gustafson D, Kaplan RC, Burk R, Qi Q. Menopausal status and observed differences in the gut microbiome in women with and without HIV infection. Menopause. 2021 01 11; 28(5):491-501.
    View in: PubMed
    Score: 0.033
  102. Pinkerton JV, Liu JH, Santoro NF, Thurston RC, Joffe H, Faubion SS, Manson JE. Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling. Menopause. 2020 06; 27(6):611-613.
    View in: PubMed
    Score: 0.032
  103. Owen CM, Pal L, Mumford SL, Freeman R, Isaac B, McDonald L, Santoro N, Taylor HS, Wolff EF. Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study. Fertil Steril. 2016 Oct; 106(5):1170-1175.e3.
    View in: PubMed
    Score: 0.024
  104. Pavlovic JM, Allshouse AA, Santoro NF, Crawford SL, Thurston RC, Neal-Perry GS, Lipton RB, Derby CA. Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles. Neurology. 2016 Jul 05; 87(1):49-56.
    View in: PubMed
    Score: 0.024
  105. Thurston RC, Santoro N, Matthews KA. Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab. 2011 Oct; 96(10):E1588-95.
    View in: PubMed
    Score: 0.017
  106. Sutton-Tyrrell K, Zhao X, Santoro N, Lasley B, Sowers M, Johnston J, Mackey R, Matthews K. Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol. 2010 Jun 01; 171(11):1203-13.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)